Radiopharm Theranostics Limited (ASX:RAD)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
At close: Mar 6, 2026
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 74.43 million as of March 6, 2026. Its market cap has increased by 32.87% in one year.
Market Cap
74.43M
Enterprise Value
38.07M
Revenue
16.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 74.43M, a decrease of -26.55%. That is a compound annual growth rate of -6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 74.43M | -16.00% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imugene | 78.77M |
| LTR Pharma | 81.80M |
| Cynata Therapeutics | 84.30M |
| Alterity Therapeutics | 87.00M |
| Prescient Therapeutics | 63.09M |
| Arovella Therapeutics | 94.16M |
| Neurizon Therapeutics | 57.16M |
| Amplia Therapeutics | 56.44M |